Company
Science
Products
Animals
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
CLOSE
R & D
Patients
Veterinarians
IR
Jobs
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
News
> IR > News
News
Events
Report
제목
플럼라인생명과학, 아프리카돼지열병 DNA백신 1,600만달러에 라이선스 아웃
작성자
관리자
등록일
20-08-19
조회수
5,296
플럼라인생명과학(222670)이 중한바이오와 아프리카돼지열병 DNA백신 ‘PLS-ASF’ 대해 1,600만달러(약 190억원) 규모의 라이선스 아웃 계약을 체결했다.
https://news.mt.co.kr/mtview.php?no=2020030310132842918
목록
공지사항
이전글
플럼라인생명과학, 내년부터 '라이프타이드®SW5' 본격생산·수출
공지사항
다음글
조셉 김 대표가 백악관에 초대되어 코로나 사태 관련 트럼프 대통령과의 제약회사 대표들과의 미팅에 참석하여 발언 하였습니다.